ENTITY

Viralytics Ltd (VLA AU)

9
Analysis
Health CareAustralia
Viralytics Ltd. is a biotechnology company. The Company uses anti-cancer virotherapy technology to treat cancer.
more
bullishViralytics Ltd
21 Jun 2018 19:56Issuer-paid

Viralytics - Termination of coverage

Edison Investment Research is terminating coverage on Viralytics (VLA). Please note you should no longer rely on any previous research or estimates...

Share
bullishViralytics Ltd
05 Dec 2017 16:13Issuer-paid

Viralytics - Looking towards pivotal Cavatak combo studies

Viralytics continues to report impressive preliminary data for Cavatak in combination with immune checkpoint inhibitors (ICIs), whether...

Share
bullishViralytics Ltd
19 Apr 2017 15:03Issuer-paid

Cavatak/Yervoy combo enters the spotlight

Viralytics’ presentations at AACR highlighted an impressive 36% response rate when melanoma patients refractory to the best available PD1/L1...

Share
bullishViralytics Ltd
09 Mar 2017 16:58Issuer-paid

Cavatak combo data at AACR next month

Viralytics will present updates on three Phase Ib trials of Cavatak in combination with marketed immune checkpoint inhibitor (ICI) drugs at the...

Share
bullishViralytics Ltd
21 Nov 2016 16:44Issuer-paid

Cavatak data continue to impress

Viralytics’ Cavatak continues to impress, with a 100% disease control rate in 10 patients (seven objective responses) in combination with Keytruda...

Share
x